Company intelligence / Profile preview

Vector Space Biosciences

San Francisco, California, United Statesx.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Currently developing countermeasures against diseases related to human spaceflight through biological CubeSats and AI-driven biological language modeling

Therapeutic areas: OtherRheumatologyOncology
Modalities: Drug repurposingNutrient-dense productsPrecision medicine
Industry: Biotech

Partnerships

NASA BioSentinel programNASA Flight OperationsAdvacamSpaceX RideshareExolaunchCal Poly – Bronco SpaceMicrosoft Azure Space

Beyond the preview

Go deeper on Vector Space Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vector Space Biosciences.

Explore the full profile